TURQUOISE-I part 2: Safety and efficacy of ombitasvir+paritaprevir/r±dasabuvir with or without RBV in patients with HIV-1 and HCV GT1 or GT4 co-infection

Category Primary study
ConferenceJournal of the International AIDS Society
Year 2016
This article has no abstract
Epistemonikos ID: 2a9a70450a333c5bae201b84a0ea43ef51fb0200
First added on: Apr 29, 2026